Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

671 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 6/13/2026

SpaceX Creates History, Becomes 6th Most Valuable US-Listed Company At $161 Share Price

SpaceX, the aerospace and AI powerhouse led by Elon Musk, roared onto the Nasdaq exchange on June 12, 2026, under the ticker SPCX, achieving a staggering $2.1 trillion market capitalization on its debut. Closing its first day at $160.95 per share after pricing at $135, the historic Initial Public Offering officially crowned Musk as the world's first trillionaire and positioned SpaceX as the sixth most valuable US-listed company. This unprecedented market entry shatters previous IPO records and signals a new era for the commercial space and artificial intelligence sectors.

Editorial Team1 min
SpaceX Creates History, Becomes 6th Most Valuable US-Listed Company At $161 Share Price
Technology 6/13/2026

Anthropic is pulling its two newest AI models after a U.S. government directive

Anthropic, the prominent AI developer, has abruptly disabled its two newest and most advanced artificial intelligence models, Claude Fable 5 and Mythos 5, for all global users following an unprecedented export control directive from the U.S. government. Issued by Commerce Secretary Howard Lutnick on Friday, June 12, 2026, just three days after their launch, the order cites unspecified national security concerns, marking a significant escalation in Washington's bid to control frontier AI technologies and raising immediate questions about future AI deployment.

Editorial Team1 min
Anthropic is pulling its two newest AI models after a U.S. government directive
Technology 6/13/2026

Meta made 'mistakes' in AI workforce shift, says CEO Mark Zuckerberg

Meta CEO Mark Zuckerberg has publicly admitted the company 'made mistakes' in its sweeping, multi-billion-dollar push to reorient its workforce around Artificial Intelligence, following a May restructuring that saw 8,000 employees laid off and another 7,000 reassigned to new AI initiatives. The admission, revealed in an internal memo, signals the immense operational challenges even tech giants face in the frantic race to dominate AI.

Editorial Team1 min
Meta made 'mistakes' in AI workforce shift, says CEO Mark Zuckerberg
Technology 6/13/2026

FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk

The U.S. Food and Drug Administration (FDA) has delivered a significant win for kidney cancer patients, approving Merck's immunotherapy Keytruda (pembrolizumab) in combination with its HIF-2α inhibitor Welireg (belzutifan) as an adjuvant treatment for adults with clear cell renal cell carcinoma (ccRCC) at intermediate-high or high risk of recurrence following surgical removal of the kidney. This landmark approval marks the first time a PD-1 and HIF-2α inhibitor combination has been greenlit, offering a crucial new post-surgery option to reduce the chance of cancer returning.

Editorial Team1 min
FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk
Technology 6/13/2026

Zuckerberg says Meta made 'mistakes' in AI workforce shift - CNA

Mark Zuckerberg, CEO of Meta, has publicly admitted that the company made 'mistakes' in its aggressive AI-driven workforce transformation, following a May restructuring that saw 8,000 employees laid off and another 7,000 reassigned to new AI initiatives. The admission, made in an internal memo, arrives amidst widespread employee discontent, particularly within the newly formed Applied AI Engineering unit, where some 'force-transferred' staff liken their experience to a 'gulag' of menial tasks. This significant overhaul underscores Meta's relentless pursuit of artificial intelligence dominance, even as it navigates internal upheaval.

Editorial Team1 min
Zuckerberg says Meta made 'mistakes' in AI workforce shift - CNA
Technology 6/13/2026

Google unveils DiffusionGemma, an AI model that breaks free of left-to-right processing

Google DeepMind has officially unveiled DiffusionGemma, an experimental open AI model that radically departs from conventional large language models' (LLMs) sequential, left-to-right processing. Launched on June 10, 2026, this innovative 26-billion-parameter model leverages text diffusion techniques, similar to those used in image generation, to create entire blocks of text simultaneously, delivering up to four times faster inference speeds on dedicated GPUs. This architectural shift targets a critical bottleneck in local, single-user AI applications, where traditional models often underutilize hardware resources.

Editorial Team1 min
Google unveils DiffusionGemma, an AI model that breaks free of left-to-right processing
Technology 6/13/2026

SpaceX, Anthropic, and OpenAI’s hot IPO summer

SpaceX's monumental public debut on June 12, which shattered records to become the largest Initial Public Offering in history with a valuation exceeding $2 trillion, signals a seismic shift in the technology investment landscape. This unprecedented listing, coupled with confidential IPO filings from AI powerhouses Anthropic and OpenAI, has officially ushered in the 'MANGOS' era, eclipsing the long-reigning FAANG cohort and reorienting Wall Street's focus towards artificial intelligence and space infrastructure.

Editorial Team1 min
SpaceX, Anthropic, and OpenAI’s hot IPO summer
Technology 6/13/2026

Samsung HBM4E, Kioxia And HPE Storage, And Peak:AIO Metadata Server

The relentless race for AI supremacy has ignited a trifecta of groundbreaking advancements in memory and storage, signaling a major leap for data-intensive computing. Samsung has begun shipping industry-first 12-layer HBM4E samples, promising a significant boost for next-generation AI workloads, while Kioxia is deepening its partnership with HPE to extend high-performance storage from terrestrial data centers to ambitious lunar exploration. Concurrently, Peak:AIO and Los Alamos National Laboratory have unveiled 'Lattice,' an open-source pNFS metadata server designed to shatter a critical bottleneck plaguing large-scale AI and High-Performance Computing (HPC) systems.

Editorial Team1 min
Samsung HBM4E, Kioxia And HPE Storage, And Peak:AIO Metadata Server
Technology 6/13/2026

World's first trillionaire: Elon Musk's net worth cross $1 trillion after SpaceX's stock market debut

Elon Musk has officially become the world's first trillionaire, a historic milestone propelled by SpaceX's record-shattering debut on the Nasdaq on June 12, 2026. The aerospace and AI titan saw its shares surge by nearly 20% on the first day of trading, rocketing the company's market capitalization past $2 trillion and anchoring Musk's personal fortune at an estimated $1.1 trillion.

Editorial Team1 min
World's first trillionaire: Elon Musk's net worth cross $1 trillion after SpaceX's stock market debut
Technology 6/13/2026

Facebook down globally: Lakhs of users report issues with app, feed and login

Meta's flagship platforms—Facebook, Instagram, and Messenger—suffered a widespread global outage on Friday, June 12, 2026, locking out millions of users and disrupting businesses worldwide. The sudden disruption, starting around 9:30 AM ET, saw users unable to log in, refresh feeds, or send messages, raising urgent questions about the resilience of critical digital infrastructure. While services largely began to restore within hours, Instagram experienced a more prolonged recovery period, leaving a significant segment of the digital economy in limbo.

Editorial Team1 min
Facebook down globally: Lakhs of users report issues with app, feed and login
Technology 6/12/2026

Why Nokia is betting on AI-powered networks

Nokia, the venerable Finnish telecom giant, is making a forceful comeback by pivoting sharply into AI-driven network infrastructure and next-generation 6G technology, underscored by a major new 'agentic AI framework' for its Network Services Platform announced just this week. This strategic reorientation has already sent its stock surging over 140% year-to-date in 2026, redefining its market perception from a legacy equipment maker to a critical player in the global AI supercycle.

Editorial Team1 min
Why Nokia is betting on AI-powered networks
Technology 6/12/2026

Encapsulation Research Advances Mission-Critical Materials

Researchers at the Johns Hopkins Applied Physics Laboratory (APL) have achieved a breakthrough in encapsulation, a technique that precisely controls the activation of reactive chemicals encased in microscopic shells. This innovation is dramatically enhancing the performance of mission-critical materials, yielding underwater adhesives that are over 500% stronger and intaglio printing inks that dry 50% faster, critical for secure document production. The advancement, led by APL scientists like Reid Messersmith, Leslie Hamilton, and Allison Moyer, promises to redefine material reliability in challenging environments.

Editorial Team1 min
Encapsulation Research Advances Mission-Critical Materials
Technology 6/12/2026

International experts issue new MRI-based prostate cancer screening guidance - Radiology Business

International experts have just unveiled a landmark new consensus, the Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM) recommendations, poised to redefine prostate cancer screening globally. Published on June 11, 2026, in JAMA Oncology, this guidance, spearheaded by Imperial College London's Dr. Nikhil Mayor, champions a streamlined, faster, and more cost-effective biparametric MRI (bpMRI) approach, aiming to improve early detection while reducing the harms associated with traditional screening.

Editorial Team1 min
International experts issue new MRI-based prostate cancer screening guidance - Radiology Business
Technology 6/12/2026

Ono Pharma submits supplemental application in Japan to expand the Use of Opdivo to treat unresectable anaplastic thyroid cancer

Ono Pharmaceutical has submitted a critical supplemental application in Japan to broaden the use of its blockbuster immunotherapy, Opdivo (nivolumab), specifically for treating unresectable anaplastic thyroid cancer (ATC). This move, based on compelling Phase 2 data from the investigator-initiated NAVIGATION study, which paired Opdivo with Eisai's Lenvima, signals a potential breakthrough against one of the most aggressive and rapidly fatal forms of cancer, offering a new lifeline where current options are severely limited. The combination therapy achieved a 47.6% objective response rate, meeting its primary endpoint with a manageable safety profile.

Editorial Team1 min
Ono Pharma submits supplemental application in Japan to expand the Use of Opdivo to treat unresectable anaplastic thyroid cancer
Technology 6/12/2026

Statin use linked to lower risk of frailty in older veterans, suggests research

A groundbreaking observational study from Mass General Brigham reveals that older U.S. veterans initiating statin therapy experienced a significant 24% lower risk of developing frailty over time. Published in the European Heart Journal, these findings suggest that the widely prescribed cholesterol-lowering medications may offer crucial healthy aging benefits far beyond their established role in cardiovascular disease prevention.

Editorial Team1 min
Statin use linked to lower risk of frailty in older veterans, suggests research
Technology 6/12/2026

Former xAI engineer sues company over AI safety concerns, claims he was laid off for speaking up

In a bombshell development, former xAI engineer Devin Kim has filed a lawsuit in California, alleging he was wrongfully terminated in September 2025 for repeatedly sounding the alarm over the safety risks of the company's Grok chatbot. Kim, who now leads the Center for AI Safety, claims his dismissal came just days before he was slated to present critical findings on Grok's potential for discrimination, harmful content generation, and even dissemination of weapons information to xAI's leadership.

Editorial Team1 min
Former xAI engineer sues company over AI safety concerns, claims he was laid off for speaking up
Technology 6/12/2026

SpaceX IPO Preview: Placing It In Context

SpaceX today made history with the largest initial public offering ever, pricing its shares at $135 and commanding a staggering $1.77 trillion valuation, instantly placing it among the world's most valuable companies upon debut. Raising approximately $75 billion in fresh capital, this unprecedented listing not only reshapes the landscape of capital markets but also positions founder Elon Musk on the brink of becoming the world's first trillionaire. The move signals a critical inflection point for the convergence of space, AI, and global connectivity, forcing a re-evaluation of how public markets value visionary, yet capital-intensive, enterprises.

Editorial Team1 min
SpaceX IPO Preview: Placing It In Context
Technology 6/12/2026

AI fast-forwards molecular simulations by 10,000-fold - Phys.org

Researchers at Sweden's Chalmers University of Technology and the University of Gothenburg have unveiled the TITO artificial intelligence model, accelerating molecular dynamics simulations by an unprecedented 10,000-fold. Published in Science Advances, this breakthrough bypasses traditional computational bottlenecks, promising to revolutionize drug discovery and materials science by rapidly predicting molecular behavior over vastly extended timescales.

Editorial Team1 min
AI fast-forwards molecular simulations by 10,000-fold - Phys.org
Technology 6/12/2026

First large-scale atlas of senescent cells could help inform future therapies for age-related diseases

A research consortium funded by the National Institutes of Health (NIH) has just unveiled the first comprehensive atlas of senescent cells across the human body, a critical breakthrough in understanding and combating age-related diseases. Published in a compendium of papers by Cell Press on June 11, this landmark effort introduces 'senotypes,' a new classification system acknowledging the diverse and heterogeneous nature of these 'zombie cells' across human tissues, marking a foundational shift towards targeted therapeutic development.

Editorial Team1 min
First large-scale atlas of senescent cells could help inform future therapies for age-related diseases
Technology 6/12/2026

HyImpulse signs letter of intent with Oman’s spaceport

German small launch provider HyImpulse has inked a pivotal Letter of Intent with Oman's burgeoning Etlaq Spaceport, signaling a strategic move to establish launch operations beyond Northern Europe. This collaboration, announced on June 2, 2026, positions Oman as an increasingly attractive hub for commercial space activities, offering HyImpulse a critical gateway to a wider range of orbital inclinations and emerging markets across the GCC, Asia, and Africa.

Editorial Team1 min
HyImpulse signs letter of intent with Oman’s spaceport
‹ Prev1…1718192021…34Next ›

Page 19 of 34 · 671 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies